Kezar Life Sciences reports positive Phase 2a data for zetomipzomib in autoimmune hepatitis, showing higher response rates and reduced steroid use.
Even as the evidence and voting trends paint a picture of a stern “no” to those linked to and found guilty of using steroids, the former Cubs slugger believes some day the tune will change.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback